Zobrazeno 1 - 10
of 2 936
pro vyhledávání: '"Dose intensity"'
Autor:
Li Jiang, Jie Zhu, Xue Chen, Yi Wang, Lei Wu, Gang Wan, Yongtao Han, Xuefeng Leng, Jun Zhang, Lin Peng, Qifeng Wang
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Many patients undergo dose reduction or early termination of chemotherapy to reduce chemoradiotherapy-related toxicity, which may increase their risk of survival. However, this strategy may result in underdosing patients with loca
Externí odkaz:
https://doaj.org/article/f8acfde563f240ffb6d95e9f14696d21
Autor:
Anton V. Snegovoy, Inessa B. Kononenko, Irina M. Radiukova, Svetlana A. Orlova, Alexander V. Sultanbaev, Daria M. Dubovichenko, Aleksandr S. Dergunov, Aleksandra F. Saidullaeva, Nadezhda N. Repina, Iuliia A. Gronskaia, Elena I. Rossokha, Tatiana V. Starostina, Oksana V. Akimova, Iuliia A. Vasil'eva, Zarina A. Godzhieva, Ol'ga Iu. Garanina, Khava I. Gorchkhanova, Iuliia S. Machekhina, Aleksandra S. Gracheva, Anastasiia E. Danilova, Tat'iana N. Dmitrakova, Vadim N. Dmitriev, Marina V. Dmitrochenko, Olga V. Dylinova, Viktoriia O. El'kova, Alla V. Zhelezniak, Irina V. Zubova, Aleksandr N. Ivanov, Liliia P. Kaleikina, Iuliia V. Komoza, Dmitrii N. Korolev, Liudmila N. Lebedeva, Andrei A. Lebedinets, Naira N. Mamedguseinova, Valeriia S. Miagkova, Elena I. Matiushina, Kristina V. Narovenkova, Valentina M. Nikolaeva, Denis V. Novikov, Galina E. Polonskaia, Olesia V. Rebrina, Mariia A. Safronova, Anna S. Semenova, Inessa A. Semenova, Roman A. Skotnikov, Ekaterina P. Solov'eva, Anna N. Tat'ianenko, Antonina A. Teterich, Vladimir N. Timin, Irina A. Tolmacheva, Iana A. Tiugina, Aleksandra V. Khodkevich, Fatima V. Tsarakhova, Iana S. Chapko, Margarita M. Shegurova, Nadezhda R. Shakurova, Anna I. Shalina, Elena A. Shumilkina, Daria V. Iakuba, Tansylu M. Ibragimova, Polina S. Feoktistova, Irina V. Sorokina, Anna M. Berezina, Polina V. Kiseleva, Olga N. Mironenko, Oxana N. Prosianikova
Publikováno v:
Современная онкология, Vol 26, Iss 2, Pp 159-171 (2024)
Aim. To evaluate the effectiveness and safety of Extimia® (empegfilgrastim, JSC "BIOCAD") in reducing the frequency, duration of neutropenia, the incidence of febrile neutropenia (FN) and infections caused by FN in patients with solid tumors receivi
Externí odkaz:
https://doaj.org/article/cbf44cb884d749adae40ccde298bbf78
Publikováno v:
Lung Cancer: Targets and Therapy, Vol Volume 15, Pp 75-80 (2024)
Alexandria TM Lee,1 Sai-Hong Ignatius Ou2 1Department of Medicine, University of California Irvine School of Medicine, Orange, CA, 92868, USA; 2Chao Family Comprehensive Cancer Center, Orange, CA, 92868, USACorrespondence: Sai-Hong Ignatius Ou, Depar
Externí odkaz:
https://doaj.org/article/239290dacf054e06a8a3547851c8fc4e
Publikováno v:
Lung Cancer: Targets and Therapy, Vol Volume 15, Pp 69-73 (2024)
Faustine X Luo,1,2 Sai-Hong Ignatius Ou1,2 1Chao Family Comprehensive Cancer Center, Orange, CA, 92868, USA; 2University of California Irvine School of Medicine, Orange, CA, 92868, USACorrespondence: Sai-Hong Ignatius Ou, University of California Irv
Externí odkaz:
https://doaj.org/article/7977f3d48c1f49229c8e7aea481cdcf7
Autor:
Ho-Young Yhim, Yong Park, Jeong-A Kim, Ho-Jin Shin, Young Rok Do, Joon Ho Moon, Min Kyoung Kim, Won Sik Lee, Dae Sik Kim, Myung-Won Lee, Yoon Seok Choi, Seong Hyun Jeong, Kyoung Ha Kim, Jinhang Kim, Chang-Hoon Lee, Ga-Young Song, Deok-Hwan Yang, Jae-Yong Kwak
Publikováno v:
The Korean Journal of Internal Medicine, Vol 39, Iss 3, Pp 501-512 (2024)
Background/Aims Optimal risk stratification based on simplified geriatric assessment to predict treatment-related toxicity and survival needs to be clarified in older patients with diffuse large B-cell lymphoma (DLBCL). Methods This multicenter prosp
Externí odkaz:
https://doaj.org/article/776c9c0704b945f3bb578ac1fc298d96
Autor:
Po‐Wei Liao, Hsueh‐Ju Lu, Tsung‐Chih Chen, Hsin‐Chen Lin, Yu‐Hsuan Shih, Chieh‐Lin Jerry Teng
Publikováno v:
Cancer Reports, Vol 7, Iss 5, Pp n/a-n/a (2024)
Abstract Background Thalidomide‐containing regimens cause adverse events (AEs) that may require a reduction in treatment intensity or even treatment discontinuation in patients with multiple myeloma. As thalidomide toxicity is dose‐dependent, ide
Externí odkaz:
https://doaj.org/article/c02b6c21982b4c64b29c29cab915b059
Publikováno v:
Current Oncology, Vol 30, Iss 11, Pp 9501-9513 (2023)
We investigated the impact of sarcopenia on adjuvant chemotherapy dosing in advanced epithelial ovarian cancer (EOC). The chemotherapy dosing and toxicity of 173 eligible patients who underwent cytoreductive surgery and adjuvant chemotherapy at a sin
Externí odkaz:
https://doaj.org/article/6eafa309341043ec8ffcdee1e9309214
Autor:
Melanie Potiaumpai, Erica A. Schleicher, Ming Wang, Kristin L. Campbell, Kathleen Sturgeon, Kathryn H. Schmitz
Publikováno v:
Cancer Medicine, Vol 12, Iss 9, Pp 10715-10724 (2023)
Abstract Background A higher chemotherapy completion rate is associated with better outcomes including treatment efficacy and overall survival. Exercise may have the potential to improve relative dose intensity (RDI) by reducing the frequency and sev
Externí odkaz:
https://doaj.org/article/d436b792039f4c99a53732c8f30c8e45
Autor:
Peiyuan Wang, Mengxia Lei, Guibin Weng, Rongfang Huang, Hui Lin, Wenwei Wei, Yujie Chen, Hao He, Peng Chen, Derong Zhang, Weijie Chen, Hang Zhou, Pengqiang Gao, Shuoyan Liu, Feng Wang
Publikováno v:
Translational Oncology, Vol 36, Iss , Pp 101736- (2023)
Background: PD-1 inhibitor and chemotherapy demonstrated durable antitumor activity with a manageable safety profile as the first-line treatment in patients with advanced esophageal squamous cell carcinoma (ESCC). The present study aimed to evaluate
Externí odkaz:
https://doaj.org/article/dfa8885efeac490db1a59e13d35a395b
Autor:
Daniel Breadner, Jonathan M. Loree, Winson Y. Cheung, Meghan Gipson, Suganija Lakkunarajah, Karen E. Mulder, Jennifer L. Spartlin, Shiying Kong, Philip Q. Ding, Sharlene Gill, Stephen A. Welch
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-6 (2022)
Abstract Background Colorectal cancer remains the second leading cause of cancer death in North America. Fluorouracil and oxaliplatin based adjuvant chemotherapy for resected colon cancer (CC) reduces cancer recurrence, but also causes significant to
Externí odkaz:
https://doaj.org/article/1d997dd7e2c34753b98355ea02900e26